Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 155

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

505	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/25/2014 9:31:05 AM
504	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/25/2014 9:03:48 AM
503	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/24/2014 3:32:58 PM
502	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/24/2014 3:03:54 PM
501	NVLX Stock Charts Last: +0.038 Monday, February	chartguy89	02/24/2014 2:57:20 PM
500	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/24/2014 2:08:13 PM
499	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/24/2014 1:16:34 PM
498	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/24/2014 12:01:27 PM
497	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/24/2014 11:25:22 AM
496	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/24/2014 10:19:36 AM
495	NVLX news:	stocklegend	02/24/2014 9:40:41 AM
494	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/24/2014 9:09:49 AM
493	Last week Nuvilex broke its previous record for a	Tandrel	02/24/2014 9:03:36 AM
492	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/24/2014 8:54:58 AM
491	NVLX Stock Charts Sunday, February 23, 2014 at	chartguy89	02/23/2014 7:15:05 PM
490	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/21/2014 4:07:22 PM
489	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/21/2014 4:07:13 PM
488	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/21/2014 2:51:38 PM
487	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/21/2014 2:18:17 PM
486	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/21/2014 12:26:07 PM
485	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/21/2014 11:21:27 AM
484	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/21/2014 10:33:37 AM
483	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/21/2014 9:42:13 AM
482	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/21/2014 9:18:15 AM
481	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/21/2014 8:57:05 AM
480	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/20/2014 3:40:15 PM
479	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/20/2014 2:26:41 PM
478	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/20/2014 1:35:08 PM
477	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/20/2014 12:39:09 PM
476	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/20/2014 11:30:17 AM
475	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/20/2014 10:48:33 AM
474	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/20/2014 10:08:03 AM
473	NVLX news:	stocklegend	02/20/2014 9:09:47 AM
472	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/20/2014 9:07:31 AM
471	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/20/2014 8:44:03 AM
470	Did everyone see the NVLX news yesterday? Nuvilex	Tandrel	02/20/2014 8:39:35 AM
469	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/19/2014 3:55:33 PM
468	$NVLX Nuvilex Accelerates Development of	stocklegend	02/19/2014 3:55:19 PM
467	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/19/2014 1:59:33 PM
466	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/19/2014 1:28:09 PM
465	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/19/2014 12:06:10 PM
464	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/19/2014 11:41:44 AM
463	NVLX news"	stocklegend	02/19/2014 11:20:52 AM
462	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/19/2014 11:20:32 AM
461	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/19/2014 8:57:18 AM
460	Nuvilex is a biotechnology company with the	Tandrel	02/19/2014 8:44:50 AM
459	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/18/2014 3:32:41 PM
458	$NVLX Nuvilex Accelerates Development of	stocklegend	02/18/2014 2:59:30 PM
457	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/18/2014 2:24:18 PM
456	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/18/2014 1:32:50 PM

Newer

Older

Recent Articles

• Digital Ally, Inc. Improves Compliance After Nasdaq Notification
• Royalty Pharma Expands Investor Engagement with Conferences
• ARMOUR Residential REIT Enhances December Dividend for Shareholders
• Quanex Building Products to Share 2024 Earnings Insights Soon
• Fundamental Global Inc. Announces Exciting Cash Dividend Update
• OneMedNet Corporation Faces Nasdaq Compliance Challenge
• Nutanix Set to Showcase Innovations at Key Investor Event
• Coherus BioSciences: Insights on Upcoming Healthcare Panel
• Marten Transport Announces Consistent Quarterly Dividend Payout
• Wing Yip Food Holdings Complete First Public Offering Success
• Globus Maritime to Announce Q3 and Nine-Month Results Soon
• Windtree Therapeutics Unveils Recent Financial Update and Insights
• Revolution Medicines to Update on Innovative RAS(ON) Therapies
• Sensei Biotherapeutics Eyes Opportunities at Upcoming Conference
• Atara Biotherapeutics Set to Showcase Innovations at Key Conference
• Innovative Tools from QIAGEN Revolutionize Microbial Analysis
• Parsons Corporation Engages Investors at Upcoming Conferences
• Glancy Prongay & Murray Probes ICON Public Limited Company Violations
• Titan Pharmaceuticals Faces Compliance Challenges with Nasdaq
• Exploring Opportunities for Hasbro, Inc. Investors Amidst Recent Lawsuit
• Applied Therapeutics Updates on Govorestat FDA Response
• Investigation of MediaAlpha, Inc. Sparks Attention for Investors
• Investigation Into Marqeta, Inc.: Key Insights for Investors
• Regeneron Pharmaceuticals Under Investigation by GPM: What Investors Need to Know
• PACS Group, Inc. Faces Class Action Amid Allegations of Fraud
• Investigation into Franklin Resources Signals Investor Concerns
• First Trust Advisors L.P. Declares Monthly Distribution for ETF
• Revolutionizing Robotics: WorkFar's Remarkable Journey Ahead
• Harley-Davidson Announces Fourth Quarter Dividend for 2024
• ASML Holding NV Class Action: What Investors Need to Know
• Boardwalktech Software: Fiscal 2025 Q2 Results Overview
• Transforming Tupperware: A New Era for Party Products LLC
• Kewaunee Scientific Corporation Announces Upcoming Earnings
• Ramaco Resources Closes Senior Unsecured Notes Offering Successfully
• iClick Interactive Reports Strong Half-Year Financial Performance
• Ohio Senator's Visit Highlights Blossom Hill's Impact on Disabled Community
• Revolutionizing Steel Maintenance: Laser Photonics CleanTech
• WellRX Enhances Preventative Care With Bioreach Acquisition
• Insights for Investors in Warner Bros. Discovery, Inc. (WBD)
• Experience the Thrill of Survival with PattieSquidGame Season 2
• Rumble Challenges California's Censorship Law in Court
• APPlife Digital Solutions Ends Collaboration with Silver Bear
• Nokia's Strategic Share Buyback Initiative Expands
• Investors Urged to Join Hasbro, Inc. Securities Lawsuit
• GemCap Solutions Restructures Auction for Loop Media Assets
• Class Action Filed on Behalf of Rentokil Initial plc Investors
• LOGISTEC Celebrates People Development Recognition in 2024
• Teamsters Rally for Enhanced Contracts in Aviation Industry
• Dmytro Gordon Engages in Critical Dialogue on Ukraine and Media Safety
• Transforming Financial Systems: QUANTUM and $Q Token Insights